Johnson RJ - Search Results

1

Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Jensen T, et al. Among authors: johnson rj. J Hepatol. 2018 May;68(5):1063-1075. doi: 10.1016/j.jhep.2018.01.019. Epub 2018 Feb 2. J Hepatol. 2018. PMID: 29408694 Free PMC article. Review.

2

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. J Am Soc Nephrol. 2001 Jul;12(7):1448-1457. doi: 10.1681/ASN.V1271448. J Am Soc Nephrol. 2001. PMID: 11423573

3

Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency.

Suga S, Mazzali M, Ray PE, Kang DH, Johnson RJ. Suga S, et al. Among authors: johnson rj. Kidney Int. 2002 Mar;61(3):951-8. doi: 10.1046/j.1523-1755.2002.00208.x. Kidney Int. 2002. PMID: 11849449 Free article.

4

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ. Mazzali M, et al. Among authors: johnson rj. Am J Physiol Renal Physiol. 2002 Jun;282(6):F991-7. doi: 10.1152/ajprenal.00283.2001. Am J Physiol Renal Physiol. 2002. PMID: 11997315 Free article.

5

Nitric oxide modulates vascular disease in the remnant kidney model.

Kang DH, Nakagawa T, Feng L, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Am J Pathol. 2002 Jul;161(1):239-48. doi: 10.1016/S0002-9440(10)64175-2. Am J Pathol. 2002. PMID: 12107108 Free PMC article.

6

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.

Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ. Watanabe S, et al. Among authors: johnson rj. Hypertension. 2002 Sep;40(3):355-60. doi: 10.1161/01.hyp.0000028589.66335.aa. Hypertension. 2002. PMID: 12215479

7

Mild hyperuricemia induces glomerular hypertension in normal rats.

Sánchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaría J, Nakagawa T, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Sánchez-Lozada LG, et al. Among authors: johnson rj. Am J Physiol Renal Physiol. 2002 Nov;283(5):F1105-10. doi: 10.1152/ajprenal.00170.2002. Am J Physiol Renal Physiol. 2002. PMID: 12372787 Free article.

8

Hyperuricemia causes glomerular hypertrophy in the rat.

Nakagawa T, Mazzali M, Kang DH, Kanellis J, Watanabe S, Sanchez-Lozada LG, Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Nakagawa T, et al. Among authors: johnson rj. Am J Nephrol. 2003 Jan-Feb;23(1):2-7. doi: 10.1159/000066303. Am J Nephrol. 2003. PMID: 12373074 Free article.

9

A role for uric acid in the progression of renal disease.

Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. Kang DH, et al. Among authors: johnson rj. J Am Soc Nephrol. 2002 Dec;13(12):2888-97. doi: 10.1097/01.asn.0000034910.58454.fd. J Am Soc Nephrol. 2002. PMID: 12444207

10

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.

Kang DH, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Curr Opin Nephrol Hypertens. 2003 Jan;12(1):43-9. doi: 10.1097/00041552-200301000-00008. Curr Opin Nephrol Hypertens. 2003. PMID: 12496665 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,470 results

Search Page